Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 14, 2025
PET-CT-based host metabolic (PETMet) features are associated with pathologic response in gastroesophageal adenocarcinomaCharlie White, Vetri Sudar Jayaprakasam, Megan Tenet, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 12, 2023
The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patientsAudrey Mauguen, Ravinder K Grewal, Finn Augensen, et al.
EJNMMI Research|October 8, 2024
[18F]TFB PET/CT misses intense [124I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancerPhilipp Backhaus, Keith S Pentlow, Alan L Ho, et al.
Bone Marrow Transplantation|September 29, 2023
T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AMLAlexandra M Satty, Elizabeth Klein, Audrey Mauguen, et al.
Bone Marrow Transplantation|May 12, 2020
Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplantVanessa A Fabrizio, Nancy A Kernan, Farid Boulad, et al.
JCO Precision Oncology|August 11, 2022
Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic RelevanceKoichi Ogura, Arielle Elkrief, Anita S Bowman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 25, 2024
First-in-Human Evaluation of Site-Specifically Labeled 89Zr-Pertuzumab in Patients with HER2-Positive Breast CancerRandy Yeh, Joseph A O'Donoghue, Vetri Sudar Jayaprakasam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2020
Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck CancerHeiko Schöder, Paula Demétrio De Souza França, Reiko Nakajima, et al.
International Journal of Cancer|September 19, 2017
Contralateral breast cancers: Independent cancers or metastases?Colin B Begg, Irina Ostrovnaya, Felipe C Geyer, et al.
Blood Advances|March 10, 2023
Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphomaChristopher J Forlenza, Jaclyn Rosenzweig, Audrey Mauguen, et al.
Pageof 13